INI-CET EXAM -2026: Which of the following statements regarding the HPV vaccine is correct?

INI-CET EXAM -2026

Pharmacology

Easy

Appeared in: INI-CET EXAM -2026

Explanation

The primary target age for HPV vaccination is 9–14 years.
This age range is recommended because the immune response to the vaccine is strongest in preteens.
Vaccination is most effective when administered before the onset of sexual activity and potential exposure to HPV.
The two-dose schedule is recommended for this age group, with doses given 6 to 12 months apart.

Option A: The standard recommendation is a two- or three-dose schedule, depending on age. While single-dose efficacy is being studied and has been adopted in some places, it is not the universal standard to replace the two-dose schedule.
Option B: This statement is incorrect on two points. First, the HPV vaccine is a recombinant, non-live vaccine using virus-like particles (VLPs). Second, it is not 100% protective and does not cover all HPV variants, although it is highly effective against the most common high-risk, cancer-causing types.
Option D: This statement describes a public health goal set by the WHO for the year 2030, not a current, universal clinical guideline or fact about the vaccine's properties. The question asks for a correct statement about the vaccine itself, and the primary target age is a more fundamental clinical fact.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Human Papillomavirus (HPV) Vaccination Guidelines as background academic context rather than a clinical decision trigger.
Nurses play a crucial role in educating parents and adolescents about the importance and safety of the HPV vaccine to improve uptake rates.
It is critical for nurses to know the correct dosing schedule based on the patient's age to ensure proper administration and completion of the vaccine series.
Understanding that the vaccine prevents cancer is a key counseling point. Nurses can dispel myths, such as the vaccine promoting sexual activity, and emphasize its role as a cancer-preventing measure.

How to Approach the Question

First, read the question carefully to understand what is being asked: a 'correct' statement about the HPV vaccine.
Evaluate each option based on your knowledge of immunization guidelines.
Option A (one dose): Recall that standard vaccine schedules for HPV are typically multi-dose. A single-dose option is not the standard rule.
Option B (live vaccine, 100% protective): Identify this as incorrect. HPV vaccines are recombinant, not live, and no vaccine is 100% effective against all variants.
Option C (target age 9-14): Recognize this as the standard recommended age for initiating vaccination for the best immune response.
Option D (90% of 15-year-olds): Identify this as a public health target or goal, not a clinical fact about the vaccine's properties or administration schedule. While factually related, it's a different category of information.

Concept Tested & Keywords

QbXL_QaKSg2J3zaAbr32rj

E6 Ghai Essential Pediatrics(pp 26-904 of 913) p. 201-203

E6 Gynecology Williams p. 211-252

E6 Medicine Harrison 22e Part 1 p. 1570-1572